These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 6126066

  • 21. Propranolol in schizophrenia. II. Clinical and biochemical aspects of combining propranolol with chlorpromazine.
    Peet M, Middlemiss DN, Yates RA.
    Br J Psychiatry; 1981 Aug; 139():112-7. PubMed ID: 7030443
    [Abstract] [Full Text] [Related]

  • 22. Neuroendocrine changes in acute schizophrenia as a function of clinical state and neuroleptic medication.
    Cotes PM, Crow TJ, Johnstone EC, Bartlett W, Bourne RC.
    Psychol Med; 1978 Nov; 8(4):657-65. PubMed ID: 364517
    [Abstract] [Full Text] [Related]

  • 23. Clinical significance of plasma chlorpromazine levels. II. Plasma levels of the drug, some of its metabolites and prolactin in patients receiving long-term phenothiazine treatment.
    Kolakowska T, Wiles DH, Gelder MG, McNeilly AS.
    Psychopharmacology (Berl); 1976 Aug 26; 49(1):101-7. PubMed ID: 8814
    [Abstract] [Full Text] [Related]

  • 24. The impact of neuroleptic dosage and extrapyramidal side effects on schizophrenic basic symptoms.
    Moritz S, Krausz M, Gottwalz E, Andresen B.
    Compr Psychiatry; 2000 Aug 26; 41(4):284-8. PubMed ID: 10929797
    [Abstract] [Full Text] [Related]

  • 25. Radio receptor assay of serum neuroleptic levels in psychiatric patients.
    Krska J, Sampath G, Shah A, Soni SD.
    Br J Psychiatry; 1986 Feb 26; 148():187-93. PubMed ID: 2870755
    [Abstract] [Full Text] [Related]

  • 26. Prolactin shifts after neuroleptic withdrawal.
    Green AI, Faraone SV, Brown WA.
    Psychiatry Res; 1990 Jun 26; 32(3):213-9. PubMed ID: 1975101
    [Abstract] [Full Text] [Related]

  • 27. Dopamine agonist treatment of schizophrenia with N-propylnorapomorphine.
    Tamminga CA, Gotts MD, Thaker GK, Alphs LD, Foster NL.
    Arch Gen Psychiatry; 1986 Apr 26; 43(4):398-402. PubMed ID: 2869745
    [Abstract] [Full Text] [Related]

  • 28. Serum neuroleptic and prolactin levels in schizophrenic patients and clinical response.
    Meltzer HY, Busch DA, Fang VS.
    Psychiatry Res; 1983 Aug 26; 9(4):271-83. PubMed ID: 6580660
    [Abstract] [Full Text] [Related]

  • 29. The effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophrenia.
    David SR, Taylor CC, Kinon BJ, Breier A.
    Clin Ther; 2000 Sep 26; 22(9):1085-96. PubMed ID: 11048906
    [Abstract] [Full Text] [Related]

  • 30. Plasma fluphenazine and prolactin levels in schizophrenic patients during treatment with low and high doses of fluphenazine enanthate.
    Wiles D, Franklin M, Dencker SJ, Johansson R, Lundin L, Malm U.
    Psychopharmacology (Berl); 1980 Sep 26; 71(2):131-6. PubMed ID: 6777812
    [Abstract] [Full Text] [Related]

  • 31. Clinical state and serum neuroleptic levels measured by radioreceptor assay in schizophrenia.
    Tune LE, Creese I, Depaulo JR, Slavney PR, Coyle JT, Snyder SH.
    Am J Psychiatry; 1980 Feb 26; 137(2):187-90. PubMed ID: 6101524
    [Abstract] [Full Text] [Related]

  • 32. [Effect of high single doses of bromocriptine in schizophrenic patients with elevated serum prolactin levels and extrapyramidal side effects associated with neuroleptic treatment (author's transl)].
    Ringwald E, Lustig A, Moscovici M, Spiegel R, Vamos E.
    Pharmakopsychiatr Neuropsychopharmakol; 1980 Nov 26; 13(6):318-24. PubMed ID: 6111093
    [Abstract] [Full Text] [Related]

  • 33. Paranoid/belligerence and neuroleptic dosage in newly admitted schizophrenic patients.
    Troisi A, Pasini A, de Angelis F, Spalletta G.
    J Clin Psychopharmacol; 1997 Apr 26; 17(2):84-7. PubMed ID: 10950468
    [Abstract] [Full Text] [Related]

  • 34. Effect of chlorpromazine treatment on prolactin levels in cerebrospinal fluid and plasma of psychotic patients.
    Wode-Helgodt B, Eneroth P, Fyrö B, Gullberg B, Sedvall G.
    Acta Psychiatr Scand; 1977 Oct 26; 56(4):280-93. PubMed ID: 335789
    [Abstract] [Full Text] [Related]

  • 35. Increased blink rates in schizophrenics. Influences of neuroleptics and psychopathology.
    Mackert A, Flechtner KM, Woyth C, Frick K.
    Schizophr Res; 1991 Oct 26; 4(1):41-7. PubMed ID: 1672606
    [Abstract] [Full Text] [Related]

  • 36. Basal and stimulated levels of prolactin, TSH and LH in serum of chronic schizophrenic patients, long-term treated with neuroleptics.
    Naber D, Ackenheil M, Laakman G, Fischer H, von Werder K.
    Pharmakopsychiatr Neuropsychopharmakol; 1980 Nov 26; 13(6):325-30. PubMed ID: 6111094
    [Abstract] [Full Text] [Related]

  • 37. Neuroleptic drug utilisation for acute schizophrenia.
    Razali MS, Hasanah CI.
    Singapore Med J; 1996 Dec 26; 37(6):611-3. PubMed ID: 9104062
    [Abstract] [Full Text] [Related]

  • 38. Neuroleptic bioavailability, psychosocial factors, and clinical status: a 1-year study of schizophrenic outpatients after dose reduction.
    Faraone SV, Curran JP, Laughren T, Faltus F, Johnston R, Brown WA.
    Psychiatry Res; 1986 Dec 26; 19(4):311-22. PubMed ID: 2880360
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Serum neuroleptic levels, prolactin levels, and relapse: a two-year study of schizophrenic outpatients.
    Faraone SV, Brown WA, Laughren TP.
    J Clin Psychiatry; 1987 Apr 26; 48(4):151-4. PubMed ID: 2881923
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.